Corvus Pharmaceuticals In... (CRVS)
NASDAQ: CRVS
· Real-Time Price · USD
5.42
0.57 (11.75%)
At close: Aug 15, 2025, 3:59 PM
5.43
0.28%
After-hours: Aug 15, 2025, 07:49 PM EDT
Corvus Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 88K | n/a | n/a | n/a | 246K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 29K | 22K | 44K | 20K | 21K | 23K | 28K | 30K | 36K | 57K | 94K | n/a | 92K | 87K | 93K | 108K | 122K | 137K |
Gross Profit | -29K | -22K | 44K | -20K | -21K | -23K | 218K | -30K | -36K | -57K | -94K | n/a | -92K | -87K | -93K | -108K | -122K | -137K |
Operating Income | -10.26M | -9.92M | -8.11M | -7.25M | -5.93M | -6.25M | -5.65M | -5.56M | -5.62M | -6.57M | -5.67M | -12.47M | -7.01M | -7.41M | -6.81M | -9.05M | -11.29M | -11.48M |
Interest Income | n/a | 525K | 508K | 566K | 434K | 316K | 380K | 425K | 403K | 376K | 318K | 225K | 100K | 11K | 7K | n/a | 1K | 3K |
Pretax Income | -8M | 15.19M | -12.11M | -40.22M | -4.26M | -5.7M | -6.65M | -6M | -6.5M | -7.87M | -9.82M | -14.83M | -8.36M | -8.3M | -9.24M | -10.67M | -11.75M | -11.58M |
Net Income | -8M | 15.19M | -12.11M | -40.22M | -4.26M | -5.7M | -6.65M | -6M | -6.5M | -8.8M | -16.2M | -14.83M | -8.26M | -8.3M | -9.24M | -10.67M | -11.75M | -11.58M |
Selling & General & Admin | 2.39M | 2.47M | 2.13M | 2.03M | 1.82M | 2.15M | 1.62M | 1.59M | 1.65M | 1.98M | 1.59M | 2.11M | 2.09M | 2.31M | 2.02M | 2.06M | 2.18M | 3.25M |
Research & Development | 7.87M | 7.45M | 5.97M | 5.22M | 4.11M | 4.08M | 4M | 3.96M | 3.97M | 4.59M | 4.08M | 10.37M | 4.92M | 5.1M | 4.79M | 6.99M | 9.11M | 8.23M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 56K | 148K | n/a | 146K | 146K | 141K | 94K | n/a | n/a |
Operating Expenses | 10.26M | 9.92M | 8.11M | 7.25M | 5.93M | 6.23M | 5.62M | 5.56M | 5.62M | 6.57M | 5.67M | 12.47M | 7.01M | 7.41M | 6.81M | 9.05M | 11.29M | 11.48M |
Interest Expense | 639K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 329K | n/a | n/a | n/a | 8K | 11K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | -23K | -28K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.26M | 9.92M | 8.11M | 7.25M | 5.93M | 6.25M | 5.65M | 5.56M | 5.62M | 6.57M | 5.67M | 12.47M | 7.01M | 7.41M | 6.81M | 9.05M | 11.29M | 11.48M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | -20.28K | n/a | n/a | n/a | 923K | 6.38M | n/a | -100K | n/a | 8K | n/a | -1K | -3K |
Shares Outstanding (Basic) | 77.77M | 72.13M | 68.35M | 66.7M | 59.71M | 47.51M | 48.02M | 48.97M | 47.5M | 46.56M | 46.55M | 46.55M | 46.55M | 46.55M | 46.55M | 43.95M | 42.25M | 34.52M |
Shares Outstanding (Diluted) | 77.77M | 75.15M | 68.35M | 66.7M | 59.71M | 49.04M | 48.02M | 48.97M | 47.5M | 46.56M | 46.55M | 46.55M | 46.55M | 46.55M | 46.55M | 43.95M | 42.25M | 34.52M |
EPS (Basic) | -0.1 | 0.21 | -0.18 | -0.6 | -0.07 | -0.12 | -0.14 | -0.12 | -0.14 | -0.19 | -0.35 | -0.32 | -0.18 | -0.18 | -0.2 | -0.24 | -0.28 | -0.34 |
EPS (Diluted) | -0.1 | -0.13 | -0.18 | -0.6 | -0.07 | -0.12 | -0.14 | -0.12 | -0.14 | -0.19 | -0.35 | -0.32 | -0.18 | -0.18 | -0.2 | -0.24 | -0.28 | -0.34 |
EBITDA | -10.26M | -9.9M | -8.09M | -7.23M | -5.91M | -6.23M | -5.62M | -5.53M | -5.59M | -6.52M | -5.57M | -12.38M | -6.92M | -7.33M | -9.13M | -10.55M | -11.17M | -11.35M |
EBIT | -8M | -9.92M | -8.11M | -7.25M | -5.93M | -6.25M | -5.63M | -5.56M | -5.62M | -6.52M | -5.52M | -12.33M | -6.87M | -7.27M | -9.23M | -10.67M | -11.29M | -11.48M |
Depreciation & Amortization | 29K | 22K | 20K | 21K | 21K | 23K | 28K | 30K | 36K | 57K | 94K | 94K | 92K | 87K | 93K | 108K | 122K | 137K |